To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip Arthroplasty

Phase 2 Not yet recruiting 40 enrolled Beijing Tide Pharmaceutical Co., Ltd The Third Affiliated Hospital of Southern Medical University · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a phase IIa, multicenter ,randomized, double-blind, placebo-controlled study designed to evaluate the safety, efficacy and kinetic characteristics of TRD205 tablets for postoperative analgesia after unilateral hip arthroplasty

Timeline

Start: 2025-09-26
Primary completion: 2025-11-20
Completion: 2025-12-27

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TRD205	Unknown	200 mg	Oral
Subject	TRD205	Unknown	400 mg	Oral
Subject	TRD205	Unknown	600 mg	Oral

Indications

No indication recorded.